SSWM
AMRI

Sheets Smith Wealth Management’s Albany Molecular Research Inc AMRI Stock Holding History

Sheets Smith Wealth Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,490
Closed -$161K – 326
2017
Q1 		$161K Hold
11,490
– – 0.04% 281
2016
Q4 		$216K Buy
+11,490
New +$195K 0.06% 260

Other funds holding AMRI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return

Sheets Smith Wealth Management's AMRI Position: Q2 2017 in Review

Sheets Smith Wealth Management sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 11,490 shares — an estimated $161K sold.

Sheets Smith Wealth Management first reported a position in AMRI in Q4 2016 and held it in 2 quarters. The position peaked at $216K in Q4 2016. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Sheets Smith Wealth Management reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 11,490 Albany Molecular Research Inc shares in Q2 2017, an estimated $161K.
  • Sheets Smith Wealth Management first reported a position in Albany Molecular Research Inc in Q4 2016 and held it in 2 quarters.
  • Sheets Smith Wealth Management's Albany Molecular Research Inc position peaked at $216K in Q4 2016.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2017, filed 19 Jul 2017.